Humana: A Great Starter Stock For Insurance Investors
Humana: Misunderstood And 35% Undervalued
Convex Strategies • 11 Comments
Convex Strategies • 11 Comments
Thu, Apr. 21, 4:16 PM
Thu, Mar. 3, 9:10 AM
- Novocure (NASDAQ:NVCR) announces that the ninth commercial payer has signed on the cover Optune. Humana (NYSE:HUM) will cover the use of the product for its members with newly diagnosed or recurrent glioblastoma, a highly malignant form of brain cancer.
- Optune is a non-invasive device that creates alternating "wave-like" electric fields called Tumor Treating Fields (TTFields). It delivers its therapy to brain tumors through four transducer arrays placed on the scalp. In a large clinical study, Optune was as effective as chemo in treating recurrent glioblastoma.
- NVCR is up 6% premarket but only on 453 shares.
Fri, Feb. 19, 11:36 AM
- Digging through this week's 13F filings, Evercore ISI's Pankal Patel and team attempt to separate the holdings of hedge funds and other active managers.
- What they found were that institutions (active managers) were most overweight Wells Fargo (NYSE:WFC), IBM, and Coca-Cola (NYSE:KO). Two new names on the overweight short-list: Level 3 Communications (NYSE:LVLT) and Zimmer Biomet (NYSE:ZBH).
- Hedge funds, on the other hand, were most overweight Time Warner Cable (NYSE:TWC), Priceline (NASDAQ:PCLN), and Netflix (NASDAQ:NFLX). Hedge funds also added to holdings of AIG, Humana (NYSE:HUM), Alphabet (GOOG, GOOGL), and EMC during Q4.
- Also of interest: While consumer discretionary stocks (NYSEARCA:XLY) continue to be the top over-weighted sector for hedge funds, they pulled back from those names considerably during the quarter, and added to tech (NYSEARCA:XLK) in a big way. They also added to their underweight in the consumer staples stocks (NYSEARCA:XLP).
Thu, Feb. 18, 4:29 PM
Tue, Feb. 16, 4:42 AM
- Aetna (NYSE:AET) has received authorization from Florida's Office of Insurance Regulation for its $37B acquisition of Humana (NYSE:HUM), securing 10 of the 20 state approvals required for the largest deal ever in the U.S. insurance industry.
- The announced mergers of Aetna and Humana, as well as Anthem's bid for Cigna, have come under increased scrutiny as the transactions would reduce the number of nationwide health insurers from five to three.
Wed, Feb. 10, 8:27 AM
Wed, Feb. 10, 7:34 AM
Tue, Feb. 9, 5:30 PM
Wed, Jan. 13, 3:23 AM
- Although still under review by the Justice Department, Aetna (NYSE:AET) Chief Executive Mark Bertolini expects the company's $37B acquisition of rival Humana (NYSE:HUM) to close this year.
- "So far, we have nothing to believe it will be any slower than that, or any faster," Bertolini said in an interview at the JP Morgan Healthcare conference.
- Anthem (NYSE:ANTM) CEO Joseph Swedish also anticipates the firm's $47B merger with Cigna (NYSE:CI) to close in 2016 - moves that will further consolidate the U.S. health insurance industry.
Nov. 19, 2015, 3:01 PM
- Medical insurers and managed care providers are taking it on the chin today. UnitedHealth Group (UNH -5.5%) brought the rain with its softer earnings guidance as a result of weaker demand for individual insurance purchased through exchanges. It seems that the premium hikes, which the Affordable Care Act was supposed to curtail, are having their predictable effect.
- Previously: UnitedHealth Group down 6% on lowered guidance (Nov. 19)
- Related tickers: (AET -7.3%)(CI -5.7%)(HUM -4.2%)(CNC -9%)(ANTM -6.8%)(WCG -4.6%)(MGLN -4.4%)(HNT -5.2%)
Nov. 6, 2015, 9:03 AM
- Humana (NYSE:HUM) Q3 results ($M): Total Revenues: 13,363 (+9.2%); Premiums: 12,987 (+11.9%); Services: 246 (-54.1%); Investment Income: 130 (+36.8%).
- Net Income: 314 (+8.3%); EPS: 2.09 (+13.0%); Non-GAAP EPS: 2.16 (+16.8%); CF Ops: 1.03B (+8.2%).
- Consolidated benefit Expense Ratio: 83.9% (+0.7%); Total Medical Membership: 14,210.1 (0%).
- Generic Dispense Rate: 89.5% (+1.4%); Script Volume: 100,600 (+20.5%).
- 2015 Guidance: EPS: $9.18 from $9.28; Non-GAAP EPS: $7.75 (unch).
Nov. 6, 2015, 8:09 AM
- Humana (NYSE:HUM): Q3 EPS of $2.16 beats by $0.03.
- Revenue of $13.36B (+9.2% Y/Y) misses by $280M.
Nov. 5, 2015, 5:30 PM
Oct. 29, 2015, 5:52 PM
- Humana (NYSE:HUM) declares $0.29/share quarterly dividend, in line with previous.
- Forward yield 0.64%
- Payable Jan. 29; for shareholders of record Dec. 30; ex-div Dec. 28.
Oct. 19, 2015, 4:52 PM
Oct. 19, 2015, 3:05 AM
- Shareholders will get their say this week on two proposed health insurer mergers: Aetna's (NYSE:AET) $37B offer for Humana (NYSE:HUM), and Centene's (NYSE:CNC) $6.3B bid for Health Net (NYSE:HNT).
- Although consumer advocates have raised concerns about whether the combination will lead to less competition and higher prices, proxy advisors ISS and Glass Lewis have given both deals a thumbs-up.
- Aetna and Humana investors are scheduled to vote this afternoon and Centene and Health Net shareholders will cast their ballots on Friday.
Humana, Inc. is a health care company that offers a wide range of insurance products and health and wellness services that incorporate an integrated approach to lifelong well-being. The company operates its business through the following segments: Retail, Employer Group, and Health and... More
Industry: Health Care Plans
Country: United States
Other News & PR